Cyrille Hulin Selected Research

Cyrille Hulin Research Topics

Disease

88	Multiple Myeloma 01/2024 - 02/2002
11	Disease Progression 10/2021 - 10/2013
8	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 08/2009
7	Neoplasms (Cancer) 01/2024 - 09/2014
6	Neutropenia 01/2023 - 08/2009
5	Residual Neoplasm 01/2022 - 12/2016
4	Lymphopenia (Lymphocytopenia) 11/2021 - 01/2019
4	Infections 01/2018 - 02/2006
3	Vomiting 01/2023 - 03/2012
2	Nausea 01/2023 - 03/2012
2	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2018
2	Sepsis (Septicemia) 11/2022 - 05/2020
2	Frailty 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 11/2021 - 01/2019
2	Febrile Neutropenia 05/2020 - 01/2019
2	Constipation 05/2012 - 03/2012
1	Rheumatic Diseases (Rheumatism) 08/2023
1	Monoclonal Gammopathy of Undetermined Significance 08/2023
1	Alopecia (Baldness) 01/2023
1	Mucositis 01/2023
1	Hypertension (High Blood Pressure) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Bone Diseases (Bone Disease) 12/2020
1	Hepatitis B 05/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2020
1	Anemia 01/2019
1	Diarrhea 10/2018
1	Leukemia 10/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2017
1	Plasma Cell Leukemia 01/2016
1	Venous Thromboembolism 10/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2012
1	Second Primary Neoplasms (Neoplasms, Second) 05/2012
1	Fatigue 05/2012
1	Sleepiness 03/2012
1	Acute Kidney Injury (Acute Renal Failure) 10/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2010
1	Pathologic Complete Response 11/2006
1	Hemorrhage 02/2006
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2002

Drug/Important Bio-Agent (IBA)

39	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 02/2006
26	Bortezomib (Velcade)FDA Link 01/2024 - 11/2006
20	Lenalidomide (CC 5013)FDA Link 12/2023 - 05/2012
20	Thalidomide (Thalomid)FDA Link 01/2023 - 11/2006
17	Melphalan (Alkeran)FDA LinkGeneric 01/2024 - 02/2002
15	daratumumabIBA 12/2023 - 01/2019
11	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2002
8	pomalidomideIBA 01/2023 - 03/2013
5	Proteasome InhibitorsIBA 10/2023 - 12/2012
4	carfilzomibIBA 01/2022 - 05/2015
4	isatuximabIBA 01/2022 - 10/2021
3	Monoclonal AntibodiesIBA 10/2023 - 01/2020
3	Immunomodulating AgentsIBA 11/2022 - 10/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018 - 01/2016
2	belantamab mafodotinIBA 10/2023 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 12/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 09/2017
2	Drug CombinationsIBA 11/2020 - 09/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2010
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023
1	Antirheumatic Agents (DMARD)IBA 08/2023
1	Janus Kinase InhibitorsIBA 08/2023
1	plerixafor FDA Link 03/2023
1	iberdomideIBA 11/2022
1	ixazomibIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 02/2021
1	fluoromethylcholineIBA 09/2020
1	Choline (Choline Chloride)IBA 05/2020
1	B-Cell Maturation AntigenIBA 01/2020
1	vasectrin IIIIBA 01/2020
1	EnzymesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Thrombin FDA Link 01/2017
1	Cytidine Monophosphate (CMP)IBA 05/2015
1	Bendamustine Hydrochloride FDA Link 02/2015
1	Vincristine (Oncovin)FDA LinkGeneric 10/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2002
1	Methylprednisolone FDA LinkGeneric 01/2002

Therapy/Procedure

26	Therapeutics 12/2023 - 02/2006
25	Stem Cell Transplantation 01/2023 - 02/2002
9	Transplantation 12/2023 - 10/2010
5	Drug Therapy (Chemotherapy) 11/2021 - 12/2003
3	Salvage Therapy 01/2023 - 05/2012
3	Intravenous Administration 10/2022 - 12/2008
2	Subcutaneous Injections 12/2012 - 12/2008
1	Hematopoietic Stem Cell Transplantation 01/2024
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023
1	Intravenous Infusions 01/2020
1	Retreatment 01/2019
1	Renal Dialysis (Hemodialysis) 10/2011
1	Autologous Transplantation 11/2008
1	Combination Drug Therapy (Combination Chemotherapy) 10/2007
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2002